SEOUL, Dec 22 (Reuters) - South Korea's Samsung Biologics (207940.KS) said on Monday it is acquiring its first U.S. drug ...
SaveHealth reports on psoriatic arthritis medications, detailing options like DMARDs, biologics, and NSAIDs, including their ...
A new study published in the Journal of American Medical Association showed that psoriasis patients who used antibiotics had ...
Located in Rockville, Maryland, GSK's Human Genome Sciences will be Samsung Biologics' first U.S.-based manufacturing site. | ...
The Maryland life sciences campus is part of a package deal alongside Human Genome Sciences, which Samsung is acquiring from ...
Scientists are literally turning back the clocks in our cells, with the first drugs about to go to human trials ...
Outlook Therapeutics received notice that the Food and Drug Administration can't approve its biologics license application for a drug designed to treat macular degeneration.
Twelve months later, Miller is healthy and preparing to host her family's holiday gathering. A regimen of biological drugs ...
South Korea's Samsung Biologics said on Monday it is acquiring its first U.S. drug production facility from GSK for $280 ...
Severe asthma is already treatable with a monthly injectable GSK drug, the blockbuster product Nucala. A new FDA approval gives the drugmaker the opportunity to reach patients with a different ...
The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback